Evidence map›Paper›PMID 30121494›Full record

ArticleEuropean journal of medicinal chemistry2018

MMB triazole analogs are potent NF-κB inhibitors and anti-cancer agents against both hematological and solid tumor cells.

Venumadhav Janganati, Jessica Ponder, Meenakshisundaram Balasubramaniam, Poornima Bhat-Nakshatri, Eli E Bar, Harikrishna Nakshatri, Craig T Jordan, Peter A Crooks

Open access · bronzeAbstract read
In one paragraph

Article in European journal of medicinal chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Application of triazoles in the structural modification of natural products.Journal of enzyme inhibition and medicinal chemistry · 2021
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Potential Treatment of Breast and Lung Cancer UsingMolecules (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Venumadhav JanganatiDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Jessica PonderDivision of Hematology, University of Colorado, Aurora, CO, 80045, USA; Department of Toxicology, University of Colorado, Aurora, CO, 80045, USA.
Meenakshisundaram BalasubramaniamDepartment of Geriatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Poornima Bhat-NakshatriDepartment of Surgery, Indiana School of Medicine, Indianapolis, IN, 46202, USA; Department of Biochemistry and Molecular Biology, Indiana School of Medicine, Indianapolis, IN, 46202, USA.
Eli E BarDepartment of Neurological Surgery, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, USA.
Harikrishna NakshatriDepartment of Surgery, Indiana School of Medicine, Indianapolis, IN, 46202, USA; Department of Biochemistry and Molecular Biology, Indiana School of Medicine, Indianapolis, IN, 46202, USA.
Craig T JordanDivision of Hematology, University of Colorado, Aurora, CO, 80045, USA; Department of Toxicology, University of Colorado, Aurora, CO, 80045, USA.
Peter A CrooksDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA. Electronic address: pacrooks@uams.edu.
University of Arkansas for Medical Sciences · USIndiana University – Purdue University Indianapolis · USUniversity of Colorado Anschutz Medical Campus · USNeurological Surgery · US

Funding

THE APOE-APP AXIS IN ALZHEIMER PATHOGENESISP01AG012411 · NIA · UNIV OF ARKANSAS FOR MED SCIS · PI GRIFFIN, SUE TILTON · 1995 to 2020
$25.0M
The Role o f Tetrahydrobiopterin (BH4) Bioavailability in Radiation-induced Skin InjuryP20GM109005 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI WOLFE, TATIANA · 2015 to 2024
$21.1M
Novel melampomagnolide B-based prodrugs for the treatment of leukemiaR01CA158275 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI CROOKS, PETER ANTHONY · 2011 to 2015
$1.6M
NCI NIH HHS R01 CA158275NIA NIH HHS P01 AG012411NIGMS NIH HHS P20 GM109005
6 · The paper itself

Abstract

Triazole derivatives of melampomagnolide B (MMB) have been synthesized via click chemistry methodologies and screened against a panel of 60 human cancer cell lines. Several derivatives showed promising anti-cancer activity, affording growth inhibition (GI

Indexed as

Antineoplastic AgentsCell Line, TumorCell ProliferationDose-Response Relationship, DrugHumansModels, MolecularMolecular StructureNF-kappa BPhosphorylationSesquiterpenesStructure-Activity RelationshipTriazolesAntineoplastic Agentsmelampomagnolide BNF-kappa BSesquiterpenesTriazolesClick chemistryLeukemia cell linesMelampomagnolide BNF-κB pathwayTriazole derivatives

Identifiers

PMID30121494
PMCPMC6281399
OpenAlexW2885312582

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.